Chemopreventive activity of sulforaphane

Xin Jiang1, Ye Liu2, Lixin Ma1

  • 1Department of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, China.

Insights

Sulforaphane (SFN), a compound in cruciferous vegetables, shows promise for cancer prevention. It protects against carcinogens and halts cancer cell growth through various molecular mechanisms, including epigenetic regulation.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Cancer remains a leading global cause of death, driven by genetic and epigenetic alterations.
  • Bioactive dietary compounds, particularly from fruits and vegetables, offer potential in cancer prevention and treatment.
  • Sulforaphane (SFN), abundant in cruciferous vegetables, exhibits significant chemopreventive effects both in laboratory and living organisms.

Purpose of the Study:

  • To review the multifaceted chemopreventive mechanisms of sulforaphane (SFN).
  • To explore SFN's role in regulating key cellular pathways involved in cancer development.
  • To highlight SFN's potential for clinical application in cancer chemoprevention strategies.

Main Methods:

  • Review of existing in vitro and in vivo studies on sulforaphane's effects.
  • Analysis of SFN's impact on drug-metabolizing enzymes (Phase I and II).
  • Investigation of SFN's influence on cell cycle regulation, apoptosis, and signaling pathways (Nrf2-Keap1, NF-κB).
  • Examination of SFN's epigenetic effects on cancer-related genes.

Main Results:

  • SFN demonstrates protective effects against environmental carcinogens.
  • SFN induces cell cycle arrest and apoptosis in various cancer cell types.
  • SFN modulates critical signaling pathways, including Nrf2-Keap1 and NF-κB.
  • SFN influences epigenetic modifications, impacting cancer initiation and progression.

Conclusions:

  • SFN possesses significant chemopreventive potential through diverse molecular mechanisms.
  • SFN's ability to regulate cellular pathways and epigenetic factors supports its role in cancer management.
  • Further research into SFN may pave the way for its clinical use in reducing cancer incidence and improving patient outcomes.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.0K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.7K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
137.9K
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
198.9K